Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 11Esophageal Squamous Cell Carcinoma 6Carcinoma, Non-Small-Cell Lung 6Rectal Neoplasms 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Head and Neck Neoplasms 3Glioblastoma 3Brain Neoplasms 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Hyperthermia 2Anus Neoplasms 2Adenocarcinoma 2Unresectable Stage III NSCLC 1Thymic epithelial tumor 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Recurrence 1Rare Diseases 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mucositis 1Metastasising Cancer of Unknown Primary 1Medulloblastoma 1Lymphoma, B-Cell, Marginal Zone 1Locally Advanced Rectal Cancer 1

Interventions

Capecitabine 7Irinotecan 5spartalizumab 3Oxaliplatin 3Neoadjuvant Therapy 3tislelizumab 1sintilimab 1nimotuzumab 1Radiotherapy 1Radiation 1Immune Checkpoint Inhibitors 1HMPL-013 1Fluorouracil 1Combined Modality Therapy 1Chemoradiotherapy 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Locally Advanced Rectal Cancer × Radiation × Clear all
NCT03702985 2019-01-23

Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer

Fudan University

Phase 2 Unknown
160 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡